FDA Inspection
South Texas Blood & Tissue CenterSouth Texas Blood & Tissue Center – FDA Inspection, Dec 11, 2013
Record Details
This FDA Inspection record concerns South Texas Blood & Tissue Center, with an inspection on December 11, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- December 11, 2013
- Product Type
- Biologics
View Company Profile
ID · 27da492a-4075-4886-873a-45e62d9362d8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 860689
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.200(a)Design appropriate, suitably located
Full citation text and observation details available on the Dashboard.
Other FDA inspections of South Texas Blood & Tissue Center
12| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2025 | Not classified | Dallas District Office | |
| June 9, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 20, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 14, 2020 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for South Texas Blood & Tissue Center
- FDA Inspection 1279560 - 2025-08-14
- FDA Inspection 1172990 - 2022-06-09
- FDA Inspection 1122018 - 2020-02-20
- FDA Inspection 1117859 - 2020-02-14
- FDA Inspection 1057467 - 2018-06-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.